Risk factors

Elutia (ELUT) risk factors

Item 1A of every Elutia Inc. 10-K on file, and what changed from one year to the next.

Open ELUT in Gloomberb →
  • FY2025 10-K risk factors

    68 risks, 11 new, 16 dropped, 17 reworded since the prior year. Elutia sold its entire cardiac device business on October 1, 2025, shifting its future results to rely on Women's Health, NXT-41x, and Cardiovascular products. The company received Nasdaq deficiency notices regarding its minimum bid price below $1.00 and market value requirements.

    Filed Mar 13, 2026
  • FY2024 10-K risk factors

    73 risks. Elutia faces going concern doubts after posting a 2024 net loss of $53.9 million alongside $23.9 million in debt.

    Filed Mar 11, 2025